Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADAG is expected to report earnings to rise 212.50% to -25 cents per share on June 03

Q1'26

Est.

$-0.25

Q4'25

Beat

by $0.15

Q2'25

Beat

by $0.10

Q4'24

Beat

by $0.18

Q2'24

Missed

by $0.03

The last earnings report on April 01 showed earnings per share of -7 cents, beating the estimate of -23 cents. With 32.95K shares outstanding, the current market capitalization sits at 225.64M.

View a ticker or compare two or three

Compare

ADAG

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ADAG

A.I. Advisor